[Federal Register: September 26, 2002 (Volume 67, Number 187)]
[Notices]               
[Page 60686-60687]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26se02-74]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-02-81]

 
Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Impact Evaluation of CDC's Arthritis Physical 
Activity Campaign: Physical Activity. The Arthritis Pain Reliever--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background

    Arthritis affects nearly 43 million Americans, or about one in 
every six people, and is the leading cause of disability among adults 
in the United States. Because of the broad public health impact of this 
disease, the Centers for Disease Control and Prevention (CDC) developed 
the National Arthritis Action Plan in 1998 as a comprehensive approach 
to reducing the burden of arthritis on the United States.
    As part of its efforts to implement the National Arthritis Action 
Plan, the CDC arthritis program developed a physical activity campaign 
for people with arthritis (PWA), specifically African American and 
Caucasian men and women aged 45-64, high school education or less, and 
annual income less than $35,000 per year. Campaign materials include 
print ads, 15-, 30- and 60-second radio public service announcements, 
and desktop displays with brochures for pharmacies, doctors' offices, 
and community centers. The campaign objectives are to increase target 
audience members' (1) Beliefs about physical activity as an arthritis 
management strategy (there are ``things they can do'' to make arthritis 
better, and physical activity is an important part of arthritis 
management); (2) Knowledge of the benefits of physical activity and 
appropriate physical activity for people with arthritis; (3) Confidence 
in their ability to be physically active, and (4) Trial of physical 
activity behaviors.
    In Spring and Summer 2002, Physical Activity. The Arthritis Pain 
Reliever is being pilot-tested by 6 CDC-funded arthritis states; 
eventually materials will be disseminated to all 38 states funded for 
arthritis programs by CDC. The preliminary pilot tests are focusing on 
reach and exposure; a more thorough evaluation is necessary to assess 
impact of the campaign. This in-depth evaluation will be used to guide 
the public health practice of the 38 CDC-funded state arthritis 
programs and their partners in determining to what extent the arthritis 
physical activity campaign has achieved its objectives.
    With the help of a contractor skilled in evaluation of health 
communication campaigns, CDC will conduct an impact evaluation using 
convenience samples in up to 12 selected geographic areas. The 
evaluation may include but not be limited to gathering information from 
the target audiences of (a) people with arthritis, and (b) physicians 
and other health care professionals through community surveys, in-
person and follow-up telephone interviews, intercept interviews, and 
other quantitative methods recommended by the evaluation contractor. 
There is no cost to respondents.

[[Page 60687]]



----------------------------------------------------------------------------------------------------------------
                                                                                          Average
                                                               Number of    Number of     burden/       Total
                         Respondents                          respondents   responses/    response   burden  (in
                                                                            respondent   (in hours)     hours)
----------------------------------------------------------------------------------------------------------------
People with Arthritis (quantitative survey).................         2000            1        20/60          667
People with Arthritis (qualitative data collection, ie.,              100            1        90/60          150
 focus groups)..............................................
MDs and other health care professionals.....................           24            1        90/60           36
                                                             --------------
    Total...................................................  ...........  ...........  ...........          853
----------------------------------------------------------------------------------------------------------------


    Dated: September 18, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-24401 Filed 9-25-02; 8:45 am]
BILLING CODE 4163-18-P